Home | Welcome to Contract Pharma   
Last Updated Tuesday, October 21 2014
Print RSS Feed

Breaking News

October 21, 2014
Will begin large-scale manufacturing  Read More »
October 21, 2014
Expands drug development and bioavailability capabilities   Read More »
October 21, 2014
Will initially be operated in the packaging area for products for the Chinese market  Read More »
October 21, 2014
9,400-square foot unit is open and equipped for early-stage human studies  Read More »
October 21, 2014
Adds new immunotherapy platforms for cancer research   Read More »
October 21, 2014
To develop new indications for shelved compounds  Read More »
October 21, 2014
To add qualified equipment and capacity at its 30 locations  Read More »
October 20, 2014
“Direct to Patient” shipping adds flexibility for clinical trial participants  Read More »
October 20, 2014
Behrens to direct finished dose and drive services in Europe  Read More »
October 20, 2014
Launches new advanceONE Division  Read More »
October 20, 2014
Recent acquisitions recover generic losses  Read More »
October 20, 2014
Will work together in Singapore for the first time  Read More »
October 20, 2014
Will study IMBRUVICA and GAZYVA in CLL/SLL/NHL  Read More »
October 20, 2014
Two other PR sites will support insulin and biologics portfolio  Read More »
October 16, 2014
BioScience revenues up 8% driven by hemophilia therapies  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On